Loo H, Saiz-Ruiz J, Costa e Silva JACE,
Ansseau M, Herrington R, Vaz-Serra A, Dilling H, de Risio S
Service Hospitalo Universitaire de Sante Mentale et de Therapeutique, Sainte-Anne Hospital, Paris, France.
J Affect Disord 1999 Dec;56(2-3):109-18
BACKGROUND: Depression is treated by a great variety of antidepressant treatments. SSRIs (such as fluoxetine) are well known: it is, however, sure that further progress is needed and the search for antidepressants with other mechanisms of action (such as tianeptine) or different efficacy is still of interest.
METHODS: A multinational study compared tianeptine with fluoxetine in 387 patients with Depressive Episode, or Recurrent Depressive Disorder, or Bipolar Affective Disorder (ICD-10), in a double-blind parallel group design. They were treated for six weeks.
RESULTS: At inclusion, no significant difference between groups was shown.
Final MADRS scores were 15.7 and 15.8 with tianeptine and fluoxetine, respectively (ITT population) (p = 0.944). MADRS responders were 58% and 56% with tianeptine and fluoxetine, respectively (p = 0.710).
No statistical difference was observed for the other efficacy parameters.
Thirty-six withdrawals occurred in each group, without any difference for the reasons of discontinuation.
There was no major difference between groups for the other safety parameters.
CONCLUSIONS: In this study, both tianeptine and fluoxetine exhibited a good efficacy and safety.